{"id":165791,"date":"2023-03-31T00:42:41","date_gmt":"2023-03-31T04:42:41","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/eisai-presented-new-analyses-of-aria-and-qol-on-lecanemab-in-clarity-ad-at-the-ad-pd-2023-annual-meeting\/"},"modified":"2024-08-18T11:45:50","modified_gmt":"2024-08-18T15:45:50","slug":"eisai-presented-new-analyses-of-aria-and-qol-on-lecanemab-in-clarity-ad-at-the-ad-pd-2023-annual-meeting","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/eisai-presented-new-analyses-of-aria-and-qol-on-lecanemab-in-clarity-ad-at-the-ad-pd-2023-annual-meeting.php","title":{"rendered":"Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD\/PD\u2122 2023 Annual Meeting"},"content":{"rendered":"<p><![CDATA[TOKYO and CAMBRIDGE, Mass., March  30, 2023  (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, \"Eisai\") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, \"Biogen\") announced today that Eisai presented new analyses on amyloid-related imaging abnormalities (ARIA) with the use of antiplatelet and anticoagulant medications, isolated ARIA-H, and caregiver burden and health-related quality of life (QOL), from the results of Eisai\u2019s Phase 3 Clarity AD study of lecanemab (generic name, U.S. brand name: LEQEMBI\u2122), an anti-amyloid-? (A?) protofibril* antibody, at the 2023 International Conference on Alzheimer\u2019s and Parkinson\u2019s Diseases annual meeting AD\/PD\u2122.]]><\/p>\n<p>Link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2023\/03\/30\/2638301\/0\/en\/Eisai-Presented-New-Analyses-of-ARIA-and-QOL-on-Lecanemab-in-Clarity-AD-at-the-AD-PD-2023-Annual-Meeting.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD\/PD\u2122 2023 Annual Meeting\">Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD\/PD\u2122 2023 Annual Meeting<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Link: Eisai Presented New Analyses of ARIA and QOL on Lecanemab in Clarity AD at the AD\/PD\u2122 2023 Annual Meeting <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/eisai-presented-new-analyses-of-aria-and-qol-on-lecanemab-in-clarity-ad-at-the-ad-pd-2023-annual-meeting.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-165791","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/165791"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=165791"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/165791\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=165791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=165791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=165791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}